XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Identifiable Intangible Assets
9 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Identifiable Intangible Assets Goodwill and Identifiable Intangible Assets
Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. The change in the carrying amount of goodwill for the nine months ended September 30, 2024 was as follows (in thousands):
Gross carrying
amount
Balance at December 31, 2023$2,724,958 
Goodwill impairment(13,078)
Write off from sale of assets(4,598)
Balance at September 30, 2024$2,707,282 
Management is required to perform an assessment of the recoverability of goodwill on an annual basis and upon the identification of a triggering event. Triggering events potentially warranting an interim goodwill impairment assessment include, among other factors, declines in historical or projected revenue, operating results or cash flows, and sustained decreases in the Company’s stock price or market capitalization. While management cannot predict if or when future goodwill impairments may occur, a non-cash goodwill impairment charge could have a material adverse effect on the Company’s operating results, net assets and the Company’s cost of, or access to, capital. The Company did not identify any triggering events indicating a possible impairment of goodwill at September 30, 2024.
During the nine months ended September 30, 2023, the Company experienced a decline in its market capitalization as a result of a sustained decrease in the Company’s stock price and also revised its financial projections. The Company considered these items to represent a triggering event and performed a goodwill impairment test as of September 30, 2023. Based on the results of the test performed as of that date, it was concluded that the estimated fair value of the Company’s reporting unit was less than its carrying value, as such, the Company recognized a non-cash goodwill impairment charge of $511.9 million during the three and nine months ended September 30, 2023.

The non-cash goodwill impairment charges included in the table above, includes $6.6 million and $6.5 million recognized during the three months ended March 31, 2024 and June 30, 2024, respectively, related to the disposition of certain immaterial custom rehab technology assets, which closed in the third quarter of 2024. The Company recognized an immaterial loss as a result of this transaction.
Identifiable intangible assets that are separable and have determinable useful lives are valued separately and amortized over the period which reflects the pattern in which the economic benefits of the assets are expected to be consumed. Identifiable intangible assets consisted of the following at September 30, 2024 and December 31, 2023 (in thousands):
September 30, 2024
Weighted-Average
Remaining Life (Years)
Tradenames, net of accumulated amortization of $47,927
$64,8736.0
Payor contracts, net of accumulated amortization of $34,366
47,6345.8
Developed technology, net of accumulated amortization of $5,355
9450.8
Identifiable intangible assets, net$113,452
December 31, 2023
Weighted-Average
Remaining Life (Years)
Tradenames, net of accumulated amortization of $38,314
$74,4866.6
Payor contracts, net of accumulated amortization of $28,216
53,7846.6
Developed technology, net of accumulated amortization of $4,410
1,8901.5
Identifiable intangible assets, net$130,160
Amortization expense related to identifiable intangible assets, which is included in depreciation and amortization, excluding patient equipment depreciation, in the accompanying statements of operations was $5.6 million and $16.7 million for the three and nine months ended September 30, 2024, respectively, and was $7.0 million and $27.0 million for the three and nine months ended September 30, 2023, respectively.
Future amortization expense related to identifiable intangible assets is estimated to be as follows (in thousands):
Twelve months ending September 30,
2025$21,828 
202619,618 
202718,190 
202817,936 
202917,936 
Thereafter17,944 
Total$113,452 
The Company did not recognize any impairment charges related to identifiable intangible assets during the nine months ended September 30, 2024 and 2023.